The Business Times
The Business Times
Subscribe
Share on FacebookShare on TwitterView more
The Business Times
Create a free account with Business Times for seamless access across SPH Media products.
REGISTER
LOGIN

Companies & Markets

SUBSCRIBERS

Novartis cancer drug may also work for Parkinson's

Published Sun, Oct 18, 2015 · 09:50 PM
Share this article.

Berlin

A NOVARTIS AG drug used for treating leukemia may also work for patients with Parkinson's disease, judging from one small and early clinical test.

An early stage trial conducted by the Georgetown University Medical Center found a small dose of the medicine, Tasigna, produced "meaningful clinical improvements" in 10 out of 11 patients, the university said in a statement on Saturday. Unlike standard clinical tests, this one did not include a control group for comparison.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here